HSR&D Citation Abstracts
Search | Search by Center | Search by Source | Keywords in Title
Jamieson HA, Nishtala PS, Scrase R, Deely JM, Abey-Nesbit R, Hilmer SN, Abernethy DR, Berry SD, Mor V, Lacey CJ, Schluter PJ. Drug burden index and its association with hip fracture among older adults: a national population-based study. The journals of gerontology. Series A, Biological sciences and medical sciences. 2018 Jul 31.
The Drug Burden Index (DBI) calculates the total sedative and anticholinergic load of prescribed medications, and is associated with functional decline and hip fractures in older adults. However, it is unknown if confounding factors influence the relationship between the DBI and hip fractures. The objective of this study is to evaluate the association between the DBI and hip fractures, after correcting for mortality and multiple potential confounding factors.
A competing risk regression analysis conducted on a prospectively recruited New Zealand community-dwelling older population who had a standardized (interRAI) assessment between 1 September 2012 and 31 October 2015, the study''s end date. Outcome measures were survival status, and hip fracture, with time-varying DBI exposure derived from 90-day time-intervals. The multivariable competing risk regression model adjusted for a large number of medical comorbidities and activities of daily living.
Among 70,553 adults assessed, 2,249 (3.2%) experienced at least one hip fracture, 20,194 (28.6%) died without experiencing a fracture, and 48,110 (68.2%) survived without a fracture. The mean follow-up time was 14.9 months (range: 1 day, 37.9 months). The overall DBI distribution was highly skewed, with median time-varying DBI exposure ranging from 0.93 (Q1=0.0, Q3=1.84) to 0.96 (Q1=0.0, Q3=1.90). DBI was significantly related to fracture incidence in unadjusted (p<0.001) and adjusted (p<0.001) analyses. The estimated subhazard ratio was 1.52 (95% confidence interval: 1.28, 1.81) for those with DBI>3 compared with those with DBI=0 in the adjusted analysis.
In this study, increasing DBI was associated with a higher likelihood of fractures after accounting for the competing risk of mortality and adjusting for confounders. The results of this unique study are important in validating the DBI as a guide for medication management and it could help reduce the risk of hip fractures in older adults.